Compounds > norethindrone

norethindrone and leptin

norethindrone has been researched along with leptin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cacciatore, B; Karonen, SL; Koistinen, HA; Laivuori, H; Ylikorkala, O1
Başak, O; Demircan, S; Karul, A; Kizilkaya, K; Köseoğlu, K; Kozaci, LD; Odabaşi, AR; Yüksel, H1
Karul, A; Kozaci, D; Odabasi, AR; Onur, E; Sezer, SD; Yuksel, H1
Ascaso, C; Balasch, J; Castelo-Branco, C; Ferrer, J; Palacios, S; Vázquez, F; Villero, J1
Alexandrou, AP; Christodoulakos, GE; Creatsas, GC; Economou, EV; Kouskouni, EE; Lambrinoudaki, IV; Panoulis, CP; Vlachou, SA1

Trials

5 trial(s) available for norethindrone and leptin

ArticleYear
Comparison between 1 year oral and transdermal oestradiol and sequential norethisterone acetate on circulating concentrations of leptin in postmenopausal women.
    Human reproduction (Oxford, England), 2001, Volume: 16, Issue:8

    Topics: Administration, Cutaneous; Administration, Oral; Body Mass Index; Climacteric; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause

2001
Effects of oral continuous 17beta-estradiol plus norethisterone acetate replacement therapy on abdominal subcutaneous fat, serum leptin levels and body composition.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2006, Volume: 22, Issue:7

    Topics: Administration, Oral; Adult; Aged; Body Composition; Body Mass Index; Body Weight; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis, Postmenopausal; Placebos; Postmenopause; Subcutaneous Fat, Abdominal; Waist-Hip Ratio

2006
Effects of standard and low dose 17beta-estradiol plus norethisterone acetate on body composition and leptin in postmenopausal women at risk of body mass index and waist girth related cardiovascular and metabolic disease.
    Saudi medical journal, 2007, Volume: 28, Issue:6

    Topics: Body Composition; Body Mass Index; Cardiovascular Diseases; Estradiol; Female; Hormone Replacement Therapy; Humans; Leptin; Metabolic Diseases; Middle Aged; Norethindrone; Norethindrone Acetate; Postmenopause; Prospective Studies; Single-Blind Method; Waist-Hip Ratio

2007
Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Fertility and sterility, 2007, Volume: 88, Issue:2

    Topics: Administration, Intranasal; Adult; Aged; Body Mass Index; Contraceptive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Leptin; Lipids; Middle Aged; Norethindrone; Placebos; Postmenopause

2007
Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene.
    Maturitas, 2008, Jan-20, Volume: 59, Issue:1

    Topics: Adult; Body Mass Index; Contraceptives, Oral, Synthetic; Estradiol; Estrogen Receptor Modulators; Estrogens; Estrogens, Conjugated (USP); Fas Ligand Protein; Female; Follicle Stimulating Hormone; Ghrelin; Hormone Replacement Therapy; Humans; Insulin; Leptin; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Raloxifene Hydrochloride; Sex Hormone-Binding Globulin

2008